Ono Pharmaceutical Co., Ltd.

80
Strong Buy
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3197600004
JPY
2,350.00
21 (0.9%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Ono Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
92,654.00
59,203.00
163,733.00
143,528.00
105,031.00
100,886.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
21,520.00
33,467.00
-28,761.00
3,784.00
-30,167.00
-10,983.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
136,821.00
82,459.00
110,660.00
159,610.00
61,829.00
73,977.00
Cash Flow from Investing Activities
-39,860.00
-136,785.00
48,077.00
-100,259.00
6,038.00
-57,586.00
Cash Flow from Financing Activities
-65,493.00
94,299.00
-89,848.00
-32,484.00
-60,237.00
-24,754.00
Net Cash Inflow / Outflow
32,480.00
38,425.00
70,005.00
27,022.00
8,066.00
-7,960.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1,012.00
-1,548.00
1,116.00
155.00
436.00
403.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Ono Pharmaceutical Co., Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
92654
241209
-1,48,555.00
-61.59%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
21520
5669
15,851.00
279.61%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
136821
213572
-76,751.00
-35.94%
Cash Flow from Investing Activities
-39860
-506137
4,66,277.00
92.12%
Cash Flow from Financing Activities
-65493
599321
-6,64,814.00
-110.93%
Net Cash Inflow / Outflow
32480
336601
-3,04,121.00
-90.35%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1012
29845
-28,833.00
-96.61%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is 65.93% vs -25.48% in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
1,36,821.00
82,459.00
65.93%